Project leads
Collaborators

Development of Angiogenesis Inhibitors

William Figg

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Neil Vargesson

University of Aberdeen

Aberdeen, United Kingdom

Christopher Schofield

University of Oxford

Oxford, United Kingdom

William Figg

National Cancer Institute (NIH)

Rockville, United States

Related projects

George Fowlis

Quantitative Biomarkers of Prostate Cancer

Kevin Brown Chandler

Impaired Glycosylation of Vascular Endothelial Growth Factor Receptor 2 in Tumor Angiogenesis

All cancers but non-melanoma skin cancer

Catherine T Yan

Lig4R278H contribution to HSC and IgH class switching defects and malignancies

All cancers but non-melanoma skin cancer

Crystal Mackall

Biology and Therapy of Lymphopenia

All cancers but non-melanoma skin cancer

Edward J Pearce

Manipulating Dendritic Cell Metabolism to Promote Cancer Immunity

All cancers but non-melanoma skin cancer

Jinsong Liu

Interleukin 1B (IL-1B) Signaling in Human Cancer Development

All cancers but non-melanoma skin cancer

Peter J Fraser

New automated experimental and computational pipeline for high coverage single-cell Hi-C and its integration with single cell RNA-seq: enabling 4D Nucleomics at single cell resolution

All cancers but non-melanoma skin cancer

Lorenzo Cohen

Community-Based, Phase III Trial of acupuncture to treat chronic Xerostomia

All cancers but non-melanoma skin cancer

Radiation Oncology

Yang Shi

Histone demethylases and regulation of chromatin and transcription in eukaryotes

All cancers but non-melanoma skin cancer